Neurological and psychiatric disorders in psoriasis-Reference-Cited by-同舟云学术

Neurological and psychiatric disorders in psoriasis

Published:2018-03-06 Issue:7 Volume:29 Page:805-813
ISSN:2191-0200
Container-title:Reviews in the Neurosciences
language:en
Short-container-title:

Author:

Amanat Man¹²,Salehi Mona¹²,Rezaei Nima³⁴⁵

Affiliation:

1. NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN) , Tehran 14194 , Iran

2. Students’ Scientific Research Center , Tehran University of Medical Sciences , Tehran 1417755331 , Iran

3. Research Center for Immunodeficiencies, Children’s Medical Center , Tehran University of Medical Sciences , Dr. Gharib St, Keshavarz Blvd , Tehran 14194 , Iran

4. Department of Immunology and Biology, School of Medicine , Tehran University of Medical Sciences , Tehran 14155-6447 , Iran

5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) , Universal Scientific Education and Research Network (USERN) , Boston, MA 1419733151 , USA

Abstract

Abstract Psoriasis used to be known as a skin disorder; however, it can now be considered as a systemic disease with the involvement of multiple organs. Neurological and psychiatric disorders are some of the associated problems that can be observed in patients with psoriasis. Stroke, multiple sclerosis, seizure, migraine, restless leg syndrome, Parkinson’s disease, Guillain-Barré syndrome, and myasthenia gravis are the reported neurological diseases, while depression, bipolar mood disorder, anxiety, psychosis, cognitive impairment, personality disorders, sexual disorders, sleep disturbance, and eating disorders are the recognized psychiatric presentations in patients with psoriasis. Herein, the neurological and psychiatric disorders of psoriasis are described.

Publisher

Walter de Gruyter GmbH

Subject

General Neuroscience

Link

https://www.degruyter.com/document/doi/10.1515/revneuro-2017-0108/pdf

Reference97 articles.

1. Abuabara, K., Azfar, R.S., Shin, D.B., Neimann, A.L., Troxel, A.B., and Gelfand, J.M. (2010). Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK. Br. J. Dermatol. 163, 586–592.

2. Aleem, D. and Tohid, H. (2017). Pro-inflammatory cytokines, biomarkers, genetics and the immune system: a mechanistic approach of depression and psoriasis. Rev. Colomb. Psiquiatr. 47. doi:10.1016/j.rcp.2017.03.002.

3. Baxter, A.J., Scott, K.M., Vos, T., and Whiteford, H.A. (2013). Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol. Med. 43, 897–910.

4. Benros, M.E., Nielsen, P.R., Nordentoft, M., Eaton, W.W., Dalton, S.O., and Mortensen, P.B. (2011). Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry 168, 1303–1310.

5. Benros, M.E., Eaton, W.W., and Mortensen, P.B. (2014a). The epidemiologic evidence linking autoimmune diseases and psychosis. Biol. Psychiatry 75, 300–306.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities;Expert Review of Clinical Pharmacology;2024-04-02

2. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials;Clinical, Cosmetic and Investigational Dermatology;2024-04

3. Psoriasis and risk of central neurological disorders in European populations: A mendelian randomization analysis;Heliyon;2024-02

4. The bidirectional causal association between psoriasis and psychological illnesses: a 2-sample Mendelian randomization study;Archives of Dermatological Research;2023-12-12

5. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT);Journal of the European Academy of Dermatology and Venereology;2023-12-12